Suppression of A beta-induced monocyte neurotoxicity by antiinflammatory compounds.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Neuroimmunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 9413254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitric oxide synthase is expressed in human macrophages during foreign body inflammation.

  1997cited by this paper
• Inflammatory mechanisms in Alzheimer disease: the role of beta-amyloid/glial interactions

  1997cited by this paper
• Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors

  1997cited by this paper
• Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils.

  1996cited by this paper
• Association of A beta 40-positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals.

  1996cited by this paper
• Inducible nitric oxide synthase in monocytes from patients with Graves' disease.

  1996cited by this paper
• Neurocytopathic effects of beta-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer disease.

  1996cited by this paper
• Inducible nitric oxide synthase of macrophages. Present knowledge and evidence for species-specific regulation.

  1996cited by this paper
• Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.

  1996cited by this paper
• Reactive Oxygen Species as Causal Agents in the Neurotoxicity of the Alzheimer's Disease‐Associated Amyloid Beta Peptide a

  1996cited by this paper
• beta-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity.

  1996cited by this paper
• Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain.

  1995cited by this paper
• Inflammation as a pathogenic mechanism in Alzheimer's disease.

  1995cited by this paper
• The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases.

  1995cited by this paper
• Macrophages and inflammatory mediators in tissue injury.

  1995cited by this paper
• Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2.

  1995cited by this paper
• Activation of microglial cells by beta-amyloid protein and interferon-gamma.

  1995cited by this paper
• A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes.

  1995cited by this paper
• Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin

  1994cited by this paper
• Inflammatory mechanisms in Alzheimer's disease: implications for therapy.

  1994cited by this paper
• Activation of macrophages by Alzheimer beta amyloid peptide.

  1994cited by this paper
• Evidence of an oxidative challenge in the Alzheimer's brain

  1994cited by this paper
• Downregulation of in vitro neurotoxicity of brain macrophages by prostaglandin E2 and a beta-adrenergic agonist.

  1994cited by this paper
• Oxygen radical‐induced neurotoxicity in spinal cord neuron cultures

  1994cited by this paper
• The effects of anti-TNF-alpha antibody and dexamethasone on TCDD-induced oxidative stress in mice.

  1994cited by this paper
• Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates

  1994cited by this paper
• Opposing Effects of Indomethacin and Nordihydroguaiaretic Acid on Macrophage Function and Tumor Growth

  1994cited by this paper
• Cytotoxicity of microglia

  1993cited by this paper
• PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances.

  1993cited by this paper
• Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma.

  1993cited by this paper
• Clinical trial of indomethacin in Alzheimer's disease

  1993cited by this paper
• Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates

  1993cited by this paper
• A simple method for the purification of human peripheral blood monocytes. A substitute for Sepracell-MN.

  1991cited by this paper
• The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease.

  1991cited by this paper
• Phagocytosis of beta/A4 amyloid fibrils of the neuritic neocortical plaques.

  1991cited by this paper
• Dexamethasone selectively regulates LPS-inducible gene expression in murine peritoneal macrophages.

  1990cited by this paper
• Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain.

  1990cited by this paper
• Anti-inflammatory drugs and Alzheimer disease.

  1990cited by this paper
• Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord

  1990cited by this paper
• Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease.

  1990cited by this paper
• Free radicals and brain damage.

  1989cited by this paper
• Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

  1987cited by this paper
• Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.

  1986cited by this paper
• The effect of immunosuppressive and anti-inflammatory drugs on monocyte function in vitro.

  1977cited by this paper

• Cognitive Status is Better in Older Adults under Colchicine Treatment: A Case-Control Study

  2022cites this paper
• PIPS one No Effect of One-Year Treatment with Indomethacin on Alzheimer ' s Disease Progression : A Randomized Controlled Trial

  2017cites this paper
• Mitochondrial transcription factor A (TFAM) as a novel intercellular signaling molecule of the brain : its role in glial cell activation and neuroinflammation

  2015cites this paper
• Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer's disease--a translational perspective.

  2014cites this paper
• Capping of Aβ42 Oligomers by Small Molecule Inhibitors

  2014cites this paper
• Mitochondrial transcription factor A (Tfam) is a pro-inflammatory extracellular signaling molecule recognized by brain microglia.

  2014cites this paper
• Inflammation and Alzheimer’s disease

  2010cites this paper
• No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial

  2008cites this paper
• NSAID use and dementia risk in the Cardiovascular Health Study*

  2008cites this paper
• Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds.

  2008cites this paper
• NSAIDs for the chemoprevention of Alzheimer's disease.

  2007cites this paper
• Colchicine therapy and the cognitive status of elderly patients with familial Mediterranean fever.

  2006cites this paper
• Microglia Activation in the Brain as Inflammatory Biomarker of Alzheimer’s Disease Neuropathology and Clinical Dementia

  2005cites this paper
• Chymotrypsin‐like proteases contribute to human monocytic THP‐1 cell as well as human microglial neurotoxicity

  2005cites this paper
• [Inflammation and Parkinson's disease].

  2004cites this paper
• Potential role of the formyl peptide receptor‐like 1 (FPRL1) in inflammatory aspects of Alzheimer’s disease

  2002cites this paper
• Receptors for chemotactic formyl peptides as pharmacological targets.

  2002cites this paper
• b Amyloid peptide (A b 42 ) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages 1

  2001cites this paper
• Postmortem studies of the effect of anti-inflammatory drugs on Alzheimer-type pathology and associated inflammation.

  2001cites this paper
• The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons.

  2001cites this paper
• Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages.

  2001cites this paper
• Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease.

  2001cites this paper
• Pleiotropic roles of formyl peptide receptors.

  2001cites this paper
• β Amyloid peptide (Aβ42) is internalized via the G‐protein‐coupled receptor FPRL1 and forms fibrillar aggregates in macrophages1

  2001cites this paper
• Inhibitory action of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxam ide (PK 11195) on some mononuclear phagocyte functions.

  2000cites this paper
• Inflammation and Alzheimer's disease.

  2000cites this paper
• Treatment of Alzheimer's disease: rationale and strategies.

  2000cites this paper
• Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells

  2000cites this paper
• Visualization of beta‐amyloid peptide (Aβ) phagocytosis by human mononuclear phagocytes: dependency on Aβ aggregate size

  2000cites this paper
• Engagement of the scavenger receptor is not responsible for beta-amyloid stimulation of monocytes to a neurocytopathic state.

  2000cites this paper
• Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides.

  2000cites this paper
• Anti-inflammatory therapy for Alzheimer's disease.

  2000cites this paper
• Brain inflammation in Alzheimer disease and the therapeutic implications.

  1999cites this paper
• The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.

  1999cites this paper
• Inflammation of the brain in Alzheimer's disease: implications for therapy

  1999cites this paper
• Toxicity of human THP-1 monocytic cells towards neuron-like cells is reduced by non-steroidal anti-inflammatory drugs (NSAIDs).

  1999cites this paper